PDCD1 and nasopharyngeal carcinoma: As programmed cell death protein 1 (PD-1) therapy only provides modest benefits for patients with recurrent metastatic (RM) nasopharyngeal carcinoma (NPC)10,11, we wondered whether asparaginase can be used for improving antitumour response in patients with NPC.